Jun 9, 2023
Puberty blockers to be given only in clinical research
Puberty blockers will only be prescribed to children attending gender identity services as part of clinical research, NHS England has announced. A clinical study, run by the new Children and Young People's Gender Dysphoria Research and Oversight Board, will look at the impact of drugs which delay puberty. An NHS spokesperson said: "The NHS is today publishing an interim specification for gender services for children and young people in line with advice and recommendations from the Independent Cass Review - this will allow the new centres to finalise their preparation for service provision later this year."The NHS is now engaging on the proposal that puberty blockers will not be made routinely available outside of research. We will develop a study into the impact of puberty blockers on gender dysphoria in children and young people with early-onset gender dysphoria, which aims to be up and running in 2024.". In order to be prescribed puberty blockers on the NHS, a patient would currently need to first be assessed by Gids and referred to an endocrinologist.
Related companies
Make a complaint about NHS England by viewing their customer service contacts.
